Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Rt Hon Sajid Javid MP Appointed Secretary of State for Health and Social Care
The Queen has been pleased to approve the appointment of the Rt Hon Sajid Javid […]
Vida Ventures Closes $825 Million Vida III Fund to Advance Transformative Biomedical Innovations
Vida Ventures (“Vida”), a next-generation life sciences venture firm, announced today the closing of Vida Ventures […]
Gliknik Inc. Raises $11.5 Million in Series C Financing
Gliknik Inc., an immunology company dedicated to patients with cancer and autoimmune disorders, today announced […]
Kurma Partners Announces the Acquisition by uniQure of Corlieve Therapeutics
uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe […]
EQRx and Exscientia Enter Strategic Drug Creation, Development, and Commercialization Collaboration to Accelerate the Advancement of New World-Class Medicines
EQRx, a company committed to developing and delivering important new medicines to patients at radically […]
Caresyntax Adds Industry Leaders to Advisory Board
Caresyntax, the leading enterprise-level digital surgery platform delivering actionable insights to make surgery smarter and […]
Recursion Announces Multi-Year Collaboration with Mila for Tech-Enabled Drug Discovery
Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, […]
Veralox Therapeutics Appoints Michael Hanna as Chief Medical Officer
Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies […]
£64 Million Funding to Back UK-wide Plan to Strengthen Clinical Research Delivery
Better health outcomes through more effective and efficient research as seen throughout the pandemic Promoting […]
NuvoAir Raises $12M in Series A Funding to Improve the Care of Millions Suffering From Lung Conditions
NuvoAir – the digital health company on a mission to improve the lives of millions […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more